This topic contains a solution. Click here to go to the answer

Author Question: Patients with damage to the _____________ are significantly less accurate on incompatible Stroop ... (Read 91 times)

viki

  • Hero Member
  • *****
  • Posts: 525
Patients with damage to the _____________ are significantly less accurate on incompatible Stroop trials than normal subjects.
 
  a. SMA c. anterior cingulate
  b. dorsolateral PFC d. ventromedial PFC

Question 2

Neurons receiving and sending information form a ________________ that is involved with short-term maintenance of working memory.
 
  a. interactive network c. feedback system
  b. cyclical communication network d. reverberatory loop



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ahernandez18

  • Sr. Member
  • ****
  • Posts: 361
Answer to Question 1

Answer: b

Answer to Question 2

Answer: d




viki

  • Member
  • Posts: 525
Reply 2 on: Jun 20, 2018
Thanks for the timely response, appreciate it


pratush dev

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Addicts to opiates often avoid treatment because they are afraid of withdrawal. Though unpleasant, with proper management, withdrawal is rarely fatal and passes relatively quickly.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library